We expect the RSK–MYPT1 signaling paradigm plays a role in migration-driven physiology, especially the invasion of cancers with activated ERK (86) and convergence during gastrulation, which requires both ERK and ROCK–MYPT1 activity (37, 87). Here, RPS6KA2 is linked to cancer.